Results 81 to 90 of about 1,744 (184)

Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects

Frontiers in Pharmacology, 2022
Objective: Omadacycline is a new type of aminomethylcycline antibiotic, having a broad antibacterial spectrum. But the pharmacokinetic characteristics and safety profile of the Chinese population remain unknown. It is also unclear whether the US-approved
Haijing Yang, Haijing Yang, Haijing Yang, Zhiwei Huang, Zhiwei Huang, Zhiwei Huang, Yuancheng Chen, Yuancheng Chen, Yuancheng Chen, Yusong Zhu, Guoying Cao, Guoying Cao, Guoying Cao, Jingjing Wang, Jingjing Wang, Jingjing Wang, Yan Guo, Yan Guo, Yan Guo, Jicheng Yu, Jicheng Yu, Jicheng Yu, Jufang Wu, Jufang Wu, Jufang Wu, Lichuan Liu, Jun Deng, Jing Liu, Harald Reinhart, Jing Zhang, Jing Zhang, Jing Zhang, Xiaojie Wu, Xiaojie Wu, Xiaojie Wu   +34 more
doaj   +1 more source

A pilot cross-sectional study of patients presenting with cellulitis to emergency departments. [PDF]

, 2014
To characterise the Emergency Department (ED) prevalence of cellulitis, factors predicting oral antibiotic therapy and the utility of the Clinical Resource Efficiency Support Team (CREST) guideline in predicting patient management in the ED setting, a ...
Milenkovski, Hristijan, O\u27Sullivan, Ronald, Quirke, Michael, Saunders, Jean, Wakai, Abel   +4 more
core   +1 more source

Long-Acting Antibiotics: New Opportunities Beyond Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)!

Antibiotics
Currently, two long-acting antibiotics are available: oritavancin (ORI) and dalbavancin (DBV) [...]
Emanuele Pontali, Giammarco Baiardi, Filippo Del Puente, Francesca Mattioli   +3 more
openaire   +3 more sources

Patient Preferences in the Emergency Department (ED) Before Treatment for Acute Bacterial Skin and Skin Structure Infection (ABSSSI) [PDF]

Open Forum Infectious Diseases, 2017
BACKGROUND: Reducing hospital admission and improving transitions of care can lessen the burden of ABSSSIs in EDs and hospitals. Limited research to date has assessed the patient’s preference for ABSSSI treatment. Understanding patient preferences may provide insights that encourage optimal treatment plans and improve satisfaction with their care ...
Abuhussain, Safa Almarzoky, Krawczynski, Michelle, Tart, Serina, Jacknin, Gabrielle, Kohman, Kelsey, Hobbs, Athena L, Nailor, Michael D, Keyloun, Katelyn R, Nicolau, David P, Kuti, Joseph L   +9 more
openaire   +1 more source

Risk Factors and Outcomes for Bloodstream Infections (BSI) Among Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) [PDF]

Open Forum Infectious Diseases, 2017
BACKGROUND: ABSSSI are common infections in the community and can result in high morbidity and healthcare costs. While risk factors for ABSSSI have been previously evaluated, risk factors associated with secondary BSI have not, especially in an urban population with limited access to healthcare.
Rybak, Michael J, Zasowski, Evan J, Trinh, Trang D, Lagnf, Abdalhamid M, Margaritis, Vasileios, Mendelsohn, Aaron B   +5 more
openaire   +1 more source

Examination of hospital length of stay in Canada among patients with acute bacterial skin and skin structure infection caused by methicillin-resistant Staphylococcus aureus

Infection and Drug Resistance, 2016
Michele H Potashman,1 Michael Stokes,2 Jieruo Liu,2 Robin Lawrence,1 Linda Harris1 1Global Health Outcomes, Merck & Co, Inc., Kenilworth, NJ, USA; 2Evidera, Lexington, MA, USA Purpose: Skin infections, particularly those caused by resistant ...
Potashman MH, Stokes M, Liu J, Lawrence R, Harris L   +4 more
doaj  

Risk Factors and Outcomes for Bloodstream Infections Among Patients with Skin Infections [PDF]

, 2016
Acute bacterial skin and skin structure infections (ABSSSI) are common infections within the local community, and they result in higher morbidity and health care costs. While risk factors for skin and soft tissue infections have been previously evaluated,
Rybak, Michael Rybak
core   +1 more source

Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective : introduction of a new treatment to the patient journey. A simulation of three European countries [PDF]

, 2019
The aim of this study was to develop a spending predictor model to evaluate the direct costs associated with the management of ABSSSIs from the National health-care provider's perspective of Italy, Romania, and Spain. METHODOLOGY: A decision-analytic
A. Marcellusi, A. Pana, A. Streinu-Cercel, Bamberger DM, D. Andretta, DiNubile MJ, D’Attis A, Mastrandrea G, Conte A, et al., F. S. Mennini, G. Favato, Health Protection Agency, J. Espin, J. P. Horcajada, L. Sarmati, M. Andreoni, M. Soro, P. Sciattella, R. Viti, Stephens JM, Ventola CL   +18 more
core   +1 more source

Clinical, organizational, and pharmacoeconomic perspectives of dalbavancin vs standard of care in the infectious disease network

Global & Regional Health Technology Assessment
Introduction: The therapeutic approach to the patient with acute bacterial skin and skin structure infection (ABSSSI) and complicated infections often involves the early transition from intravenous to oral therapy (early switch) or early discharge.
Daniela Segala, Marco Barbieri, Mariachiara Di Nuzzo, Melissa Benazzi, Aurora Bonazza, Letizia Romanini, Brunella Quarta, Kristian Scolz, Anna Marra, Diana Campioni, Rosario Cultrera   +10 more
doaj   +1 more source

Tedizolid Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis

Antibiotics, 2019
This meta-analysis aims to assess the efficacy and safety of tedizolid, compared to linezolid, in the treatment of acute bacterial skin and skin structure infection (ABSSSI). PubMed, Web of Science, EBSCO (Elton B.
Shao-Huan Lan, Wei-Ting Lin, Shen-Peng Chang, Li-Chin Lu, Chien-Ming Chao, Chih-Cheng Lai, Jui-Hsiang Wang   +6 more
doaj   +1 more source